Evidence for oxazepam as an in vivo probe of UGT2B15:...

British Journal of Clinical Pharmacology 2009 Vol. 68; Iss. 5

Evidence for oxazepam as an in vivo probe of UGT2B15: oxazepam clearance is reduced by UGT2B15 D85Y polymorphism but unaffected by UGT2B17 deletion

Xi He, Leah M. Hesse, Suwagmani Hazarika, Gina Masse, Jerold S. Harmatz, David J. Greenblatt, Michael H. Court
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
68
Year:
2009
Language:
english
Pages:
10
DOI:
10.1111/j.1365-2125.2009.03519.x
File:
PDF, 827 KB
english, 2009
Conversion to is in progress
Conversion to is failed